VISTAGEN THERAPEUTICS, INC. Preferred Stock Dividends and Other Adjustments
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Preferred Stock Dividends and Other Adjustments of $353.60 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2021-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2021-02-11
- VISTAGEN THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2020-12-31 was $353.60K, a 9.88% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2020-09-30 was $347.20K, a 10.64% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2020-06-30 was $335.80K, a 11.01% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2019-12-31 was $321.80K, a 10.62% increase year-over-year.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 3 month as first filed | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 6 month as first filed | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 9 month as first filed |
|---|---|---|---|---|---|---|
| 2020-12-31 | $353.60K 10-Q · filed 2021-02-11 | $700.80K derived: sum of 2 quarters · filed 2021-02-11 | $1.04M 10-Q · filed 2021-02-11 | |||
| 2020-09-30 | $347.20K 10-Q · filed 2020-11-12 | $683.00K 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | $335.80K 10-Q · filed 2020-08-13 | |||||
| 2019-12-31 | $321.80K 10-Q · filed 2021-02-11 | $635.60K derived: sum of 2 quarters · filed 2021-02-11 | $938.10K 10-Q · filed 2021-02-11 | |||
| 2019-09-30 | $313.80K 10-Q · filed 2020-11-12 | $616.30K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $302.50K 10-Q · filed 2020-08-13 | |||||
| 2018-12-31 | $290.90K 10-Q · filed 2020-02-13 | $574.50K derived: sum of 2 quarters · filed 2020-02-13 | $848.00K 10-Q · filed 2020-02-13 | |||
| 2018-09-30 | $283.60K 10-Q · filed 2019-11-07 | $557.10K 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | $273.50K 10-Q · filed 2019-08-13 | |||||
| 2017-12-31 | $263.00K 10-Q · filed 2019-02-12 | $519.30K derived: sum of 2 quarters · filed 2019-02-12 | $766.60K 10-Q · filed 2019-02-12 | |||
| 2017-09-30 | $256.30K 10-Q · filed 2018-10-29 | $503.60K 10-Q · filed 2018-10-29 | ||||
| 2017-06-30 | $247.30K 10-Q · filed 2018-08-14 | |||||
| 2016-12-31 | $237.70K 10-Q · filed 2018-02-12 | -$237.70K 10-Q · filed 2017-02-13 | $478.70K derived: sum of 2 quarters · filed 2018-02-12 | $1.02M 10-Q · filed 2018-02-12 | -$1.02M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $241.00K 10-Q · filed 2017-11-09 | -$241.00K 10-Q · filed 2016-11-14 | $780.80K 10-Q · filed 2017-11-09 | -$780.80K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $539.80K 10-Q · filed 2017-08-14 | -$539.80K 10-Q · filed 2016-08-12 | ||||
| 2015-12-31 | -$631.30K 10-Q · filed 2017-02-13 | -$1.25M derived: sum of 2 quarters · filed 2017-02-13 | -$1.46M 10-Q · filed 2017-02-13 | |||
| 2015-09-30 | -$614.70K 10-Q · filed 2016-11-14 | -$828.00K 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | -$213.30K 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |